Although some discrepancies exist over the relationship between CRP levels in NAFLD, most studies report increased circulatory CRP levels, which is a known marker for systemic inflammation, during NAFLD (76). The gene discussed is CRP; the disease is metabolic dysfunction-associated steatotic liver disease.